Having received an MSc in Biotechnology from Bangalore University (2009), Veeranjaneyulu, then worked in the pharmaceutical industry as a Quality Control Analyst and Research Assistant in Dr. Reddy's Laboratories, India (2009-2011). During this time, he obtained a Postgraduate Diploma in Intellectual Property Rights Law (Patents) from the prestigious National Law School of India University (2010). He moved to the UK in late 2011 and received a master's degree in chemistry with professional practice (2014) and a Ph.D. in Chemistry from Biomolecular and Materials Interface Research Group led by Professor Carole C. Perry, Nottingham Trent University (2018). As part of his professional practice degree, he spent a year working as a Research Scientist at Cellular Systems Grantham Ltd (Biocity, Nottingham) on a commercial project titled "Adding value to food waste - the retrieval of high value materials from eggshell waste". His Ph.D. was focussed on isolating material-binding peptides by phage display and verifying them bioinformatically and/or experimentally (invitro binding studies); exploring/understanding the binding mechanisms occurring at bioinorganic interface and the physico-chemical factors responsible for the adsorption/ desorption of biomolecules (eg. amino acid, peptide, phage) on nanomaterial surfaces in solution.
Veeranjaneyulu is now working as a Biophysical Analyst within the School of Pharmacy at the University of Nottingham to support the commercial, industrial and research operations of the School of Pharmacy relating to the field of biophysical analysis. He works as part of the Interface and Surface Analysis Centre (ISAC) and the Molecular Therapeutics and Formulation (MTF) research division to provide consultancy, experimental and technical support to new and ongoing projects.
Skilled in designing, developing and validating analytical methods for research projects including patents evaluation and technology transfer. Strong knowledge and understanding of the formulation and development of tablets, capsules, generic drugs and healthcare products. Solid understanding and experience of peptide and nanoparticle synthesis, characterization and interface interaction studies. Expertise in identifying ligands/peptides that bind specifically to a given target. These material-binding peptides derived from phage display act as smart tools with applications in biomedicine (eg. engineering antibodies, drug delivery) and nanobiotechnology (eg. nanomaterial synthesis, assembly and fabrication).